1. Enhanced glucose control improves vibration perception thresholds in type 1 diabetes patients

    Nice study by Dahlin et al. out of Sweden showed improved glucose control as measured by Hb A1c levels led to improved vibration perception threshold (VPT) in Type I diabetes patients. This is yet another paper implying improvement in neurological function is possible in those patients with diabetic peripheral neuropathy (DPN). This goes against long […]

  2. ETF128 International Sales

    The company is pleased to announce increasing ETF international sales over the past year. Our distribution agreement with US Neurologicals has largely driven these overseas orders. We look forward to accelerating this distribution channel  in the coming months.    ETF128 and ETFMx international sales destinations 2019-20.

  3. All Tuning Forks Are Not Created Equal

    A 2015 study performed at the University of Maine compared the vibration output of several commercially available 128 Hz tuning forks to the ETF128. A biothesiometer was also tested to show the output of this instrument at the 25v level. As the graphic below shows, the frequency and amplitude varied considerably. Our current ETF128 model […]

  4. ETF Proof-of-Concept Study Cited in Two International Practice Guideline Documents

    Although the International Federation of Diabetes (IDF) put out these clinical practice guidelines in 2017, we were gratified to see our 2014 ETF Proof-of-Concept study cited on page 19 of the document. We are cited in the section on using a 128 Hz tuning fork to assess diabetic peripheral neuropathy. We were equally excited to […]